India Allergy Diagnostics Market (2026-2031)
The India Allergy Diagnostics Market was valued at $166.7 Million in 2026 and projected to reach to $303.7 Million by 2031, representing a compound annual growth rate of 12.8%. India's allergy diagnostics market is poised for substantial growth over the forecast period, driven by increasing disease prevalence, rising healthcare awareness, and expanding diagnostic infrastructure.
India Allergy Diagnostics Market Trends and Insights
- This 12.8% compound annual growth rate reflects India's rising prevalence of allergic diseases, increasing healthcare awareness, and expanding diagnostic infrastructure across urban and semi-urban regions.
- India's growing middle class and improved access to advanced testing technologies are driving demand for accurate allergy identification and management solutions. The Indian market is characterized by a shift toward point-of-care testing and immunoassay-based diagnostics, supported by government healthcare initiatives and private sector investments.
- India's pharmaceutical and diagnostic companies are increasingly developing cost-effective allergy testing solutions tailored to local patient populations.
- Between 2026 and 2031, India is expected to witness accelerated adoption of molecular and component-resolved diagnostics, driven by rising air pollution, changing lifestyle patterns, and enhanced reimbursement policies that make allergy testing more accessible to India's diverse demographic segments..
Key Market Statistics
- CAGR (2026-2031) 12.8% CAGR
- Market Size, 2026 ~USD 166.7 Million
- Forecast, 2031 ~USD 303.7 Million
- Country India
India Allergy Diagnostics Market Overview
Rapid Market Expansion :
India's allergy diagnostics market is projected to grow from USD 166.7 million in 2026 to USD 303.7 million by 2031, representing a robust 12.8% CAGR, significantly outpacing the global growth rate of 9.6%.
Rising Allergic Disease Prevalence :
Increasing prevalence of allergic conditions across India's urban and semi-urban populations, driven by environmental factors, lifestyle changes, and improved disease awareness among healthcare providers and patients.
Growing Middle Class & Healthcare Access :
India's expanding middle class coupled with improved healthcare infrastructure and diagnostic capabilities in tier-2 and tier-3 cities is driving demand for advanced allergy diagnostic solutions and testing services.
Enhanced Diagnostic Infrastructure :
Significant investments in diagnostic centers, pathology labs, and hospital infrastructure across India are enabling wider accessibility to allergy testing and improving early disease detection rates.
India Allergy Diagnostics Market Dynamics
- The 12.8% CAGR reflects strong demand from both urban centers and emerging semi-urban markets as more patients seek professional allergy testing and diagnosis.
- Growing healthcare expenditure and the emergence of specialized diagnostic centers are creating new opportunities for market players. The market's expansion is further supported by India's rising middle class, improved access to healthcare services, and increasing adoption of advanced diagnostic technologies.
- Government initiatives promoting healthcare accessibility and private sector investments in diagnostic infrastructure are expected to accelerate market growth.
- By 2031, the market is anticipated to reach USD 303.7 million, establishing India as a significant growth hub for allergy diagnostics in the Asia-Pacific region..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Key Takeaways
- India's allergy diagnostics market will grow from USD 166.7 million in 2026 to USD 303.7 million by 2031, representing a 12.8% CAGR.
- Rising air pollution, urbanization, and lifestyle changes in India are significantly increasing allergic disease prevalence and diagnostic demand.
- India's expanding healthcare infrastructure and government initiatives are improving access to allergy testing across urban and rural populations.
- Cost-effective, locally-developed diagnostic solutions are positioning India as a key hub for affordable allergy testing innovation in Asia Pacific.
Allergy Diagnostics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | IN VITRO TESTS (Test Type) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 9.6% from 2026 to 2031 |
| Largest Segment | CONSUMABLES (Product & Service) |
| Market Size Base Year (Billions) | ~USD 6.81 (2026) |
| Revenue Forecast (Billions) | ~USD 10.77 (2031) |
| Segments Covered | Product & Service, Type, Test Type, Allergen, End User |
India Allergy Diagnostics Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product & Service
- Consumables
- Instruments
- Services
By Type
- Immunoassay Analyzers
- Luminometers
- Other In Vivo Tests
- Other Instruments
- Patch Tests
- Skin Prick Tests
By Test Type
- In Vitro Tests
- In Vivo Tests
By Allergen
- Drug Allergens
- Food Allergens
- Inhaled Allergens
- Other Allergens
By End User
- Academic Research Institutes
- Diagnostic Laboratories
- Hospital-Based Laboratories
- Other End Users
Target Audience
- Diagnostic Equipment Manufacturers : Need India-specific market data to assess demand for allergy diagnostic devices, plan manufacturing capacity, and identify distribution partnerships in a rapidly expanding market with 12.8% growth potential.
- Healthcare Facility Operators : Require detailed market insights to justify investments in allergy diagnostic services, understand patient demand patterns, and develop service expansion strategies across India's urban and semi-urban regions.
- In Vitro Diagnostics (IVD) Companies : Need comprehensive India market analysis to guide product development, pricing strategies, and go-to-market approaches for allergy testing kits and reagents in a high-growth emerging market.
- Healthcare Investors & Private Equity : Require validated market sizing and growth forecasts for India to evaluate investment opportunities in diagnostic centers, pathology chains, and healthcare technology companies in the allergy diagnostics space.
- Healthcare Consultants & Strategy Firms : Need India-specific market data and trend analysis to support client advisory services, competitive benchmarking, and strategic planning for healthcare organizations entering or expanding in the diagnostics sector.
Key Companies in the India Allergy Diagnostics Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| TECAN GROUP LTD. | Switzerland |
TECAN GROUP LTD.
TECAN GROUP LTD. is a Swiss life sciences company providing laboratory automation and diagnostic instruments.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise market valuation data for India (USD 166.7M in 2026) with verified 12.8% CAGR projections through 2031, enabling accurate business planning and investment decisions specific to the Indian market.
- Competitive Positioning Strategy : Understand India's unique market dynamics, regional growth patterns, and diagnostic infrastructure expansion to develop targeted competitive strategies and identify market entry or expansion opportunities.
- Investment & Expansion Planning : Access detailed India-specific insights to support capital allocation decisions, facility expansion plans, and partnership strategies aligned with the country's 12.8% growth trajectory and healthcare infrastructure development.
- Regulatory & Market Landscape : Gain comprehensive understanding of India's healthcare regulatory environment, diagnostic standards, and market structure to navigate compliance requirements and optimize market penetration strategies.
- Customer Segment Identification : Identify and prioritize high-potential customer segments across India's urban, semi-urban, and emerging markets with data-driven insights on healthcare provider adoption and patient demand patterns.
Frequently asked questions
What is the projected size of India's allergy diagnostics market by 2031?
India's allergy diagnostics market is projected to reach USD 303.7 million by 2031, growing from USD 166.7 million in 2026 at a 12.8% CAGR.
What factors are driving growth in India's allergy diagnostics market?
Key drivers include rising air pollution, increasing urbanization, changing lifestyle patterns, growing healthcare awareness, expanding diagnostic infrastructure, and improved reimbursement policies across India.
Which diagnostic technologies are gaining traction in India?
India is witnessing increased adoption of point-of-care testing, immunoassay-based diagnostics, molecular diagnostics, and component-resolved diagnostics tailored to local patient populations.
How is India's healthcare infrastructure supporting allergy diagnostics growth?
Government healthcare initiatives, private sector investments, and expansion of diagnostic facilities in urban and semi-urban regions are making allergy testing more accessible across India's diverse demographics.
What role do Indian companies play in the allergy diagnostics market?
Indian pharmaceutical and diagnostic companies are developing cost-effective, locally-tailored allergy testing solutions, positioning India as a key innovation hub for affordable diagnostics in Asia Pacific.
RESEARCH METHODOLOGY
The study involved major activities in estimating the current market size for the global Allergy Diagnostic market. Exhaustive secondary research was done to collect information on the allergy diagnostic market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market sizes of the allergy diagnostic market's segments and subsegments.
Secondary Research
This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ in-house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the allergy diagnostic market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, VPs/managing directors, marketing heads/directors and sales directors, marketing/sales managers, regional/area sales managers, export/import heads/managers, and other market-related personnel from various companies and organizations operating in the allergy diagnostic market. Primary sources from the demand side included vice presidents in hospitals & clinics, C-level executives, department heads, doctors/physicians, hospital supply management teams, clinic personnel, and laboratory technicians.
Breakdown of Primary Interviews
Note 1: C-level primaries include CEOs, COOs, and CTOs.
Note 2: Others include sales managers, marketing managers, and product managers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3 = <USD 500 million
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the allergy diagnostic market. These methods were also widely used to estimate the sizes of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The market was divided into four segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the market engineering process and arrive at precise statistics for all segments.
Approach to derive the market size and estimate market growth: Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of allergy diagnostic products. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.
Market Definition
Allergy testing helps determine the substances causing a patient's allergy symptoms. Tests include skin tests, intradermal tests, challenge tests, blood tests, and patch tests. Allergists commonly conduct challenge tests, including food, inhalation, drug, and physical challenges. Blood tests are generally used when unsafe or unapplicable skin tests are required, such as when consuming certain medications or having a skin condition that may interfere with skin testing. Allergy tests, such as in vitro & in vivo tests, are performed to determine the cause, stage, prognosis, and treatment course for allergic diseases.
Key Stakeholders
- Allergy Diagnostic Reagents, Kits, and Instrument Manufacturers
- Allergy Diagnostic Vendors and Distributors
- Hospitals
- Diagnostic Laboratories
- Allergy Diagnostic Service Providers
- Academic Research Institutes
- Venture Capitalists and Investors
- Contract Research Organizations (CROs)
Report Objectives
- To describe, analyze, and forecast the allergy diagnostic market, by product & service, test type, allergen, end user, and region
- To describe and forecast the allergy diagnostic market for key regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries
- To provide detailed information regarding drivers, restraints, opportunities, and challenges influencing the growth of the allergy diagnostic market
- To strategically analyze the ecosystem, regulations, patenting trend, value chain, Porter’s Five Forces, and prices pertaining to the market under study
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To profile key players and comprehensively analyze their market shares and core competencies in the allergy diagnostic market
- To analyze competitive developments such as collaborations, acquisitions, product launches, expansions, and R&D activities in the allergy diagnostic market
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of each company
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific allergy diagnostic market into Vietnam, New Zealand, and others
- Further breakdown of the Rest of Latin America allergy diagnostic market into Colombia, Chile, Ecuador, and others
- Further breakdown of the Rest of Europe allergy diagnostic market into Belgium, Russia, the Netherlands, Switzerland, and others
Get the Full Allergy Diagnostics Market Report
Full forecast, segment splits, and company analysis for all Allergy Diagnostics Market.
- Canada Allergy Diagnostics Market
- US Allergy Diagnostics Market
- Germany Allergy Diagnostics Market
- UK Allergy Diagnostics Market
- France Allergy Diagnostics Market
- Italy Allergy Diagnostics Market
- Spain Allergy Diagnostics Market
- China Allergy Diagnostics Market
- Japan Allergy Diagnostics Market
- South Korea Allergy Diagnostics Market
- Australia Allergy Diagnostics Market
- Brazil Allergy Diagnostics Market
- Mexico Allergy Diagnostics Market
- GCC Countries Allergy Diagnostics Market
- Rest Of Europe Allergy Diagnostics Market
- Rest Of Asia Pacific Allergy Diagnostics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report